HFM
AZN icon

Harvest Fund Management’s AstraZeneca AZN Stock Holding History

Harvest Fund Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
5,158
-16,634
-76% -$3.21M 0.04% 169
2025
Q4 		$4.01M Buy
21,792
+3,764
+21% +$660K 0.15% 108
2025
Q3 		$2.77M Buy
18,028
+1,108
+7% +$168K 0.12% 123
2025
Q2 		$2.36M Sell
16,920
-1,472
-8% -$206K 0.11% 131
2025
Q1 		$2.7M Buy
18,392
+1,257
+7% +$182K 0.13% 118
2024
Q4 		$2.25M Buy
17,135
+3,723
+28% +$521K 0.1% 132
2024
Q3 		$2.09M Buy
13,412
+4,602
+52% +$743K 0.12% 118
2024
Q2 		$1.37M Buy
8,810
+237
+3% +$35.7K 0.1% 125
2024
Q1 		$1.16M Buy
8,573
+6,014
+235% +$796K 0.1% 128
2023
Q4 		$343K Buy
2,559
+267
+12% +$34.7K 0.05% 152
2023
Q3 		$310K Buy
2,292
+748
+48% +$102K 0.05% 156
2023
Q2 		$221K Buy
1,544
+665
+76% +$97.8K 0.04% 183
2023
Q1 		$122K Buy
879
+53
+6% +$7.13K 0.03% 286
2022
Q4 		$112K Buy
826
+371
+82% +$46.5K 0.03% 315
2022
Q3 		$50K Buy
455
+422
+1,279% +$53.5K 0.01% 419
2022
Q2 		$4K Hold
33
– – ﹤0.01% 666
2022
Q1 		$4K Hold
33
– – ﹤0.01% 700
2021
Q4 		$3K Hold
33
– – ﹤0.01% 739
2021
Q3 		$3K Buy
+33
New +$3.84K ﹤0.01% 730
2020
Q3 		– Sell
-101
Closed -$10K – 530
2020
Q2 		$10K Buy
+101
New +$10.4K ﹤0.01% 442

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Harvest Fund Management's AZN Position: Q1 2026 in Review

Harvest Fund Management reduced its AstraZeneca (AZN) stake by 76% in Q1 2026, selling an estimated $3.21M and leaving 5,158 shares worth $1.02M. The position accounts for 0.04% of the portfolio, ranked #169.

Harvest Fund Management first reported a position in AZN in Q2 2020 and has held it in 20 quarters since. The position peaked at $4.01M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Harvest Fund Management held 5,158 shares of AstraZeneca worth $1.02M as of Q1 2026.
  • Harvest Fund Management sold 16,634 AstraZeneca shares in Q1 2026, an estimated $3.21M.
  • AstraZeneca made up 0.04% of Harvest Fund Management's portfolio in Q1 2026, its #169 holding.
  • Harvest Fund Management first reported a position in AstraZeneca in Q2 2020 and has held it in 20 quarters since.
  • Harvest Fund Management's AstraZeneca position peaked at $4.01M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.